Sumeet Patiyal

Mr. Sumeet Patiyal

Senior Research Fellow
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2020 in Briefings in Bioinformatics
Verified
Journal Article
Closed access
NSNeelam Sharma
Neelam Sharma
Sumeet PatiyalSumeet Patiyal
Sumeet Patiyal
ADAnjali Dhall
Anjali Dhall
APAkshara Technology Pande
Akshara Technology Pande
CAChakit Arora
Chakit Arora
Gajendra P S RaghavaGajendra P S Raghava
Gajendra P S Raghava
AlgPred 2.0 is a web server developed for predicting allergenic proteins and allergenic regions in a protein. It is an updated version of AlgPred developed in 2006. The dataset used for training, testing and validation consists of 10 075 allergens and 10 075 non-allergens. In addition, 10 451 experimentally validated immunoglobulin E (IgE) epitopes were used to identify antigenic regions in a protein. All models were trained on 80% of data called training dataset, and the performance of models was evaluated using 5-fold cross-validation technique. The performance of the final model trained on the training dataset was evaluated on 20% of data called validation dataset; no two proteins in any two sets have more than 40% similarity. First, a Basic Local Alignment Search Tool (BLAST) search has been performed against the dataset, and allergens were predicted based on the level of similarity with known allergens. Second, IgE epitopes obtained from the IEDB database were searched in the dataset to predict allergens based on their presence in a protein. Third, motif-based approaches like multiple EM for motif elicitation/motif alignment and search tool have been used to predict allergens. Fourth, allergen prediction models have been developed using a wide range of machine learning techniques. Finally, the ensemble approach has been used for predicting allergenic protein by combining prediction scores of different approaches. Our best model achieved maximum performance in terms of area under receiver operating characteristic curve 0.98 with Matthew’s correlation coefficient 0.85 on the validation dataset. A web server AlgPred 2.0 has been developed that allows the prediction of allergens, mapping of IgE epitope, motif search and BLAST search (https://webs.iiitd.edu.in/raghava/algpred2/).

9 October 2020 in Briefings in Bioinformatics
Verified
Journal Article
Closed access
ADAnjali Dhall
Anjali Dhall
Sumeet PatiyalSumeet Patiyal
Sumeet Patiyal
NSNeelam Sharma
Neelam Sharma
SUSalman Sadullah Usmani
Salman Sadullah Usmani
Gajendra P S RaghavaGajendra P S Raghava
Gajendra P S Raghava
Interleukin 6 (IL-6) is a pro-inflammatory cytokine that stimulates acute phase responses, hematopoiesis and specific immune reactions. Recently, it was found that the IL-6 plays a vital role in the progression of COVID-19, which is responsible for the high mortality rate. In order to facilitate the scientific community to fight against COVID-19, we have developed a method for predicting IL-6 inducing peptides/epitopes. The models were trained and tested on experimentally validated 365 IL-6 inducing and 2991 non-inducing peptides extracted from the immune epitope database. Initially, 9149 features of each peptide were computed using Pfeature, which were reduced to 186 features using the SVC-L1 technique. These features were ranked based on their classification ability, and the top 10 features were used for developing prediction models. A wide range of machine learning techniques has been deployed to develop models. Random Forest-based model achieves a maximum AUROC of 0.84 and 0.83 on training and independent validation dataset, respectively. We have also identified IL-6 inducing peptides in different proteins of SARS-CoV-2, using our best models to design vaccine against COVID-19. A web server named as IL-6Pred and a standalone package has been developed for predicting, designing and screening of IL-6 inducing peptides (https://webs.iiitd.edu.in/raghava/il6pred/).

1 April 2021 in Heliyon
Verified
Journal Article
Open access
ACAnita Chaudhary
Anita Chaudhary
SBSherry Bhalla
Sherry Bhalla
Sumeet PatiyalSumeet Patiyal
Sumeet Patiyal
Gajendra P S RaghavaGajendra P S Raghava
Gajendra P S Raghava
GSGirish Sahni
Girish Sahni
Globally fermented foods are in demands due to their functional and nutritional benefits. These foods are sources of probiotic organisms and bioactive peptides, various amino acids, enzymes etc. that provides numerous health benefits. FermFooDb (https://webs.iiitd.edu.in/raghava/fermfoodb/) is a manually curated database of bioactive peptides derived from wide range of foods that maintain comprehensive information about peptides and process of fermentation. This database comprises of 2205 entries with following major fields, peptide sequence, Mass and IC50, food source, functional activity, fermentation conditions, starter culture, testing conditions of sequences in vitro or in vivo, type of model and method of analysis. The bioactive peptides in our database have wide range of therapeutic potentials that includes antihypertensive, ACE-inhibitory, antioxidant, antimicrobial, immunomodulatory and cholesterol lowering peptides. These bioactive peptides were derived from different types of fermented foods that include milk, cheese, yogurt, wheat and rice. Numerous, web-based tools have been integrated to retrieve data, peptide mapping of proteins, similarity search and multiple-sequence alignment. This database will be useful for the food industry and researchers to explore full therapeutic potential of fermented foods from specific cultures.

11 August 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
VKVinod Kumar
Vinod Kumar
Sumeet PatiyalSumeet Patiyal
Sumeet Patiyal
ADAnjali Dhall
Anjali Dhall
NSNeelam Sharma
Neelam Sharma
Gajendra P S RaghavaGajendra P S Raghava
Gajendra P S Raghava
The blood–brain barrier is a major obstacle in treating brain-related disorders, as it does not allow the delivery of drugs into the brain. We developed a method for predicting blood–brain barrier penetrating peptides to facilitate drug delivery into the brain. These blood–brain barrier penetrating peptides (B3PPs) can act as therapeutics, as well as drug delivery agents. We trained, tested, and evaluated our models on blood–brain barrier peptides obtained from the B3Pdb database. First, we computed a wide range of peptide features. Then, we selected relevant peptide features. Finally, we developed numerous machine-learning-based models for predicting blood–brain barrier peptides using the selected features. The random-forest-based model performed the best with respect to the top 80 selected features and achieved a maximal 85.08% accuracy with an AUROC of 0.93. We also developed a webserver, B3pred, that implements our best models. It has three major modules that allow users to predict/design B3PPs and scan B3PPs in a protein sequence.

8 February 2022 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
SJShipra Jain
Shipra Jain
ADAnjali Dhall
Anjali Dhall
Sumeet PatiyalSumeet Patiyal
Sumeet Patiyal
Gajendra P S RaghavaGajendra P S Raghava
Gajendra P S Raghava

1 June 2024 in Drug Discovery Today
Verified
Journal Article
Closed access
SJShipra Jain
Shipra Jain
SGSrijanee Gupta
Srijanee Gupta
Sumeet PatiyalSumeet Patiyal
Sumeet Patiyal
Gajendra P S RaghavaGajendra P S Raghava
Gajendra P S Raghava